QUREuniQure N.V.

$1B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+1198.5% YoY

Gross Profit

$2M7.0% margin

Operating Income

-$8M-24.2% margin

Net Income

-$699,000-2.1% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+1805.3%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$40M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$340M

Total Liabilities

$96M

Stockholders' Equity

$244M

Cash & Equivalents

$245M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$3M	+1198.5%
Gross Profit	$2M	-$24M	+110.1%
Operating Income	-$8M	-$33M	+74.9%
Net Income	-$699,000	-$41M	+98.3%

Revenue Segments

License Revenue From Related Party

$30M100%

Collaborative Revenue From Related Party

$61,0000%

QURE Q4 2020 Earnings — uniQure N.V. Revenue & Financial Results | Market Cap Arena